Pyxis Oncology Insider Trades

PYXS

Track insider trading activity from Pyxis Oncology executives and directors. See which insiders are buying and selling PYXS stock.

Trades Last 12 Months

PYXS Price

All Insider Trades for Pyxis Oncology

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Humphrey Rachel Director
Holding Value $78k 45,867 shares
Last Trade
Mar 24, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$62.4k 45,867 shares
$1.36
$1.70
Holding Value $78k 45,867 shares
Last Trade
Mar 24, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$62.4k 45,867 shares
$1.36
$1.70
Wadhane Jitendra Prin Fin & Acct Officer
Holding Value $872k 512,882 shares
Last Trade
Mar 24, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$506k 372,096 shares
$1.36
$1.70
Cline Darren S Director
Holding Value $78k 45,867 shares
Last Trade
Mar 24, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$62.4k 45,867 shares
$1.36
$1.70
Palani Santhosh Director
Holding Value $78k 45,867 shares
Last Trade
Mar 24, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$62.4k 45,867 shares
$1.36
$1.70
Holding Value $78k 45,867 shares
Last Trade
Mar 24, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$62.4k 45,867 shares
$1.36
$1.70
Dupont Jakob Director
Holding Value $78k 45,867 shares
Last Trade
Mar 24, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$62.4k 45,867 shares
$1.36
$1.70
Flavin John L Director
Holding Value $78k 45,867 shares
Last Trade
Mar 24, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$62.4k 45,867 shares
$1.36
$1.70
Civik Thomas Interim CEO
Holding Value $1.17M 690,131 shares
Last Trade
Feb 03, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.03M 690,131 shares
$1.49
$1.70
Sullivan Lara President ,ceo & CMO
Holding Value $1.56M 918,308 shares
Last Trade
Mar 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$900k 918,308 shares
$0.98
$1.70
Holding Value $62.9k 36,979 shares
Last Trade
Mar 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$36.2k 36,979 shares
$0.98
$1.70
Holding Value $704k 414,163 shares
Last Trade
Mar 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$406k 414,163 shares
$0.98
$1.70
Kobayashi Ken Chief Medical Officer
Holding Value $754k 443,514 shares
Last Trade
Dec 29, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$998k 554,392 shares
$1.80
$1.70
Feingold Jay Chief Medical Officer
Holding Value $0 0 shares
Last Trade
Mar 24, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$38.7k 17,517 shares
$2.21
$1.70
Holding Value $1.01M 594,313 shares
Last Trade
Mar 24, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$735k 332,569 shares
$2.21
$1.70
Pfizer Inc 10% owner
Holding Value $10.1M 5,952,263 shares
Last Trade
Mar 17, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5M 1,811,594 shares
$2.76
$1.70
Chin Mark Director
Holding Value $0 0 shares
Last Trade
Apr 21, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.63M 1,745,761 shares
$2.65
$1.70
Holding Value $0 0 shares
Last Trade
Oct 13, 2021 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$208M 17,438,534 shares
$11.92
$1.70
Holding Value $1.14M 668,854 shares
Last Trade
Oct 13, 2021 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$7.97M 668,854 shares
$11.92
$1.70
Herbst Ronald Chief Scientific Officer
Holding Value $48k 28,252 shares
Last Trade
Oct 07, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$1.70

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up